Clinical Practice Update: Management of Infectious Endophthalmitis After Intravitreal Anti-VEGF Injection

Rohan Merani, Mark W. Johnson, Colin A. McCannel, Harry W. Flynn, Ingrid U. Scott, Alex P. Hunyor

Research output: Contribution to journalReview articlepeer-review

1 Scopus citations


Although infectious endophthalmitis after intravitreal antivascular endothelial growth factor injections is rare, it is the most feared and potentially devastating complication of this procedure. There is no high-level evidence to provide definitive guidance on the management of endophthalmitis occurring after intravitreal injection (IVI). This clinical practice update reviews the published literature regarding post-IVI endophthalmitis and highlights areas in which further research is needed to better guide its management.

Original languageEnglish (US)
Pages (from-to)443-451
Number of pages9
JournalJournal of VitreoRetinal Diseases
Issue number6
StatePublished - Nov 1 2022

All Science Journal Classification (ASJC) codes

  • Ophthalmology

Cite this